AGP Executive Report
Last update: 11 hours agoSleep Apnea Breakthrough: Apnimed’s once-daily pill AD109 hit its main goal in a late-stage trial, cutting breathing interruptions in obstructive sleep apnea by 55.6% vs placebo—aimed at patients who can’t tolerate CPAP. Pregnancy Drug Warning Push: Public Citizen filed a supplemental petition urging the FDA to add explicit pregnancy contraindications for modafinil and armodafinil, citing higher rates of major congenital malformations in a long-running pregnancy registry. Hantavirus Watch (Canada-linked): Canada’s first hantavirus case remains tied to the MV Hondius cruise outbreak, with ongoing monitoring and “low-risk” contact follow-ups as Europe weighs how to respond. Heat Health Alerts: Environment Canada issued yellow heat warnings for parts of Ontario, including Hamilton and Windsor-Essex, urging checks on at-risk people and watch for heat exhaustion signs. World Cup Health Context: Measles and other infectious-disease concerns are rising ahead of the 2026 tournament co-hosted by Canada, as travel and crowding amplify risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/fca48961-cefc-45dd-8d98-25f89f10318d/north-america-orthopedic-soft-tissue-repair-market-size-2025-to-2035-usd-billion-.png)
